These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3079082)

  • 1. Tumor recurrence after liver transplantation followed by high-dose cyclophosphamide, total body irradiation, and autologous bone marrow transplantation for treatment of metastatic liver disease.
    Margreiter R; Niederwieser D; Frommhold H; Schönitzer D; Gratwohl A; Huber C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2403-4. PubMed ID: 3079082
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver transplantation followed by high-dose cyclophosphamide, total-body irradiation, and autologous bone marrow transplantation for treatment of metastatic breast cancer. A case report.
    Huber C; Niederwieser D; Schönitzer D; Gratwohl A; Buckner D; Margreiter R
    Transplantation; 1984 Mar; 37(3):311-2. PubMed ID: 6367168
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
    Chen TL; Kennedy MJ; Anderson LW; Kiraly SB; Black KC; Colvin OM; Grochow LB
    Drug Metab Dispos; 1997 May; 25(5):544-51. PubMed ID: 9152592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience using bone marrow transplantation in the treatment of hematologic neoplasms and solid tumors].
    Niederwieser D; Aulitzky W; Frommhold H; Schönitzer D; Url M; Allerberger F; Wiegele J; Gratwohl A; Braunsteiner H; Huber C
    Wien Klin Wochenschr; 1987 Jan; 99(2):49-53. PubMed ID: 3551339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation.
    Shpall EJ; Anderson IC; Bast RC; Joines WT; Jones RB; Ross M; Edwards S; Eggleston S; Johnston C; Tepperberg M
    Prog Clin Biol Res; 1990; 333():321-35; discussion 336. PubMed ID: 2308989
    [No Abstract]   [Full Text] [Related]  

  • 7. Trial of high-dose cytarabine, cyclophosphamide, total-body irradiation, and autologous marrow transplantation for refractory lymphoma.
    Armitage JO; Gingrich RD; Klassen LW; Bierman PJ; Kumar PP; Weisenburger DD; Smith DM
    Cancer Treat Rep; 1986 Jul; 70(7):871-5. PubMed ID: 3521847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
    Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
    Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
    Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
    Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.
    Rohatiner AZ; Nadler L; Davies AJ; Apostolidis J; Neuberg D; Matthews J; Gribben JG; Mauch PM; Lister TA; Freedman AS
    J Clin Oncol; 2007 Jun; 25(18):2554-9. PubMed ID: 17515573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
    Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation.
    Anderson JE; Appelbaum FR; Schoch G; Barnett T; Chauncey TR; Flowers ME; Storb R
    Biol Blood Marrow Transplant; 2001; 7(3):163-70. PubMed ID: 11302550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I-II trial of high-dose cyclophosphamide, carboplatin and autologous bone marrow or peripheral blood stem cell rescue.
    Spitzer TR; Cirenza E; McAfee S; Foelber R; Zarzin J; Cahill R; Mazumder A
    Bone Marrow Transplant; 1995 Apr; 15(4):537-42. PubMed ID: 7655378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
    Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
    Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer.
    Peters WP; Ross M; Vredenburgh JJ; Hussein A; Rubin P; Dukelow K; Cavanaugh C; Beauvais R; Kasprzak S
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):25-31. PubMed ID: 7916487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High-dose cyclophosphamide and whole-body radiotherapy followed by bone marrow transplant in patients with leukemia].
    Fernández-Rañada JM; Vázquez L; Lozano M; Fernández-Garese D; Figuera A; Arranz R; González N; Gómez N; Fernández Villalta MJ; Gómez-Reino F
    Rev Clin Esp; 1987 Mar; 180(5):247-52. PubMed ID: 3299537
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
    Chen TL; Passos-Coelho JL; Noe DA; Kennedy MJ; Black KC; Colvin OM; Grochow LB
    Cancer Res; 1995 Feb; 55(4):810-6. PubMed ID: 7850794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
    Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
    J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow transplantation using TBI and CBV for disseminated high/intermediate grade cutaneous non-epidermotropic non-Hodgkin's lymphoma.
    Moreau P; LeTortorec S; Mahé MA; Mahé B; Moreau A; Bourdin S; Bulabois CE; Bureau B; Harousseau JL; Milpied N
    Bone Marrow Transplant; 1994 Nov; 14(5):775-8. PubMed ID: 7889011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of poor prognosis non-Hodgkin's lymphoma using cyclophosphamide and total body irradiation regimens with autologous bone marrow rescue.
    Braine HG; Santos GW; Kaizer H; Yeager AM; Mann RB; Burns WH; Civin CI; Fuller DJ; Rowley SD; Saral R
    Bone Marrow Transplant; 1987 Jun; 2(1):7-14. PubMed ID: 3332159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.